As with all peptides so far, Leary about this one as well. After trying igf-1 lr3, des, and mgf, seems like they are either bs since it isn't pharma igf, it it just doesn't hold up on paper and pharma gh reigns superior by a longshot from my experience.
Now, myostatin inhibitors, follistatin...